New Feature: Search Alerts are available now. Learn more.
Skip to main content

Pfizer-Wyeth Merger Agreement, Provisions Related to Cash and Stock Considerations, Financing, and Termination and Reverse Fees


Book Publication Date: Nov 2019
Description: This document contains provisions of the merger agreement entered into on January 25, 2009 pursuant to which Pfizer was to acquire Wyeth, two publicly held firms. The provisions relate principally to the stock and cash consideration to be paid by Pfizer, the financing conditions to the transaction and the Termination and Reverse Termination Fees.
Type: Other Document Templates, Contract Clauses
PLI Item #: 41248
Practice Area: Corporate & Securities
Keywords: "Pfizer-Wyeth Merger Agreement, Provisions Related to Cash and Stock Considerations, Financing, and Termination and Reverse Fees"; "contract law drafting principles"; representations and warranties of company; "representations and warranties of parent and merger sub"; "covenants relating to conduct of business"; "effect on capital stock"; covenants relating to conduct of business; financing cooperation; termination and amendment

Thank you for exploring PLI PLUS.
The content on this page is only available to subscribers.

To learn more about PLI PLUS subscriptions
please click on the link below or contact us at PLUS@pli.edu.